Vaccinia Virus Vector Bivalent Norovirus Vaccine
Norovirus is a major etiological agent of nonbacterial gastroenteritis around the world. Due to its in vitro culture complexity, high genome diversity, and the lack of cross-reactive immunity between genogroups, there is an unmet urgent need for polyvalent norovirus vaccines that provide broad-spect...
Saved in:
| Main Authors: | Yunbo Bai, Xi Wu, Yanru Shen, Liangliang Wang, Ziqi Cheng, Yeqing Sun, Hao Wu, Qingfeng Zhang, Ziqi Sun, Chenchen He, Binfan Liao, Weijin Huang, Huanzhang Xia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/2/237 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Mpox Multi-Antigen-Tandem Bivalent mRNA Candidate Vaccine Effectively Protects Mice Against the Vaccinia Virus
by: Jun Zuo, et al.
Published: (2025-03-01) -
Enhanced construction of a bivalent adenovirus-based vaccine for preventing childhood pathogens: Human respiratory syncytial virus and norovirus
by: Ying-Chin Chen, et al.
Published: (2025-04-01) -
Recombinant VP1 protein of norovirus GII.4 (Caliciviridae: <i>Norovirus</i>) is capable to induse the production of cross-reacting antibodies
by: Vladislav A. Lapin, et al.
Published: (2025-07-01) -
Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults
by: Geert Leroux-Roels, et al.
Published: (2025-01-01) -
Identification of Co-29, a 5-cyano-2-thiacetyl aromatic pyrimidinone, as a potential inhibitor targeting the RdRp of norovirus
by: Xianglan Liu, et al.
Published: (2025-04-01)